Alzheimer's Disease: Untapped Potential for Pharmacy January 18, 2017By Jill SederstromPharmacists can become the perfect partner in the battle against Alzheimer’s disease. Details here. The year's Top Drugs December 19, 2016By Monica Shah PharmDSpecialty medications dominate Analyst: CVS’ OptumRx deal amps up competition December 06, 2016By Christine BlankLast month, OptumRx and CVS Pharmacy announced that they are partnering to provide more convenient choices and lower costs for patients. Are states going too far with painkiller script limits? December 06, 2016By Christine BlankArizona has become the latest state to limit opioid prescriptions—a trend that has some healthcare providers and experts concerned. Generic drugs save U.S. $227 billion November 01, 2016By Christine BlankGeneric drugs produced $227 billion in savings for the U.S. healthcare system in 2015 Will docs prescribe the new RA biosimilars? October 07, 2016By Christine BlankWhile FDA recently approved two new biosimilars for rheumatoid arthritis and other inflammatory diseases, questions remain about how quickly physicians and patients will embrace the new drugs. Medicare drug spending spike shows need for generics September 10, 2016By Christine BlankAn exclusive Associated Press report found that Medicare’s spending on certain drugs soared by 85% in two years. Study: Biosimilars as safe as branded drugs August 12, 2016By Christine BlankNew study finds that biosimilar medications for arthritis and other diseases areas safe and effective as their brand-name counterparts. FDA approves rolapitant to prevent chemotherapy-induced nausea and vomitingRolapitant is a novel NK1 receptor antagonist that maintains >90% receptor binding up to five days after a single 180-mg dose. FDA warns about oral antifungal use during pregnancy June 10, 2016By Christine BlankA Danish study has found a possibility of increased risk of miscarriage in pregnant women who use oral fluconazole to treat yeast infections.